Craig Camasta, DPM
Podiatrist · Atlanta, GANPI 1235131079
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.6%), travel and lodging and royalties or licence payments — rather than concentrated in one kind of arrangement. Pacira Pharmaceuticals Incorporated accounts for 73.6% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2019 at $30,950 and has fallen 87.6% since, to $3,851 in 2025. Among podiatrist clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $298.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$36K
- Flower Orthopedics Coporation$9K
- United Orthopedics LLC$1K
- Medshape, Inc.$301
- Treace Medical Concepts, Inc.$222
- Stryker$208
- plus $2K from 31 others
What the payments were for
- Royalty or licence$4,97510%
- Consulting fees$4,81610%
- Speaking & faculty fees$23,17548%
- Travel & lodging$9,65220%
- Food & beverage$4,81810%
- Education$1,2042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 60 | $35,802 |
| Flower Orthopedics Coporation | 29 | $8,905 |
| United Orthopedics LLC | 1 | $1,200 |
| Medshape, Inc. | 2 | $301 |
| Treace Medical Concepts, Inc. | 2 | $222 |
| Stryker(2 entities) | 3 | $208 |
| Averitas Pharma Inc. | 2 | $195 |
| Alafair Biosciences, Inc. | 1 | $183 |
| Amgen(2 entities) | 10 | $164 |
| Medline Industries LP | 1 | $162 |
| Nevro Corp. | 4 | $137 |
| Sanara Medtech Inc. | 1 | $116 |
| Paratek Pharmaceuticals, Inc. | 5 | $113 |
| Zyla Life Sciences, Inc. | 10 | $111 |
| Organogenesis Inc. | 1 | $103 |
| Bioventus LLC | 3 | $90 |
| Smith+Nephew | 3 | $87 |
| ANI Pharmaceuticals, Inc. | 2 | $57 |
| Integra Lifesciences Corporation | 2 | $46 |
| International Life Sciences | 1 | $40 |
| Triad Life Sciences Inc. | 2 | $39 |
| Polynovo North America LLC | 1 | $39 |
| Johnson & Johnson | 2 | $38 |
| Zimmer Biomet | 1 | $38 |
| Aroa Biosurgery Incorporated | 2 | $36 |
| Sebela Pharmaceuticals Inc. | 1 | $26 |
| Kerecis Limited | 1 | $25 |
| Medtronic | 1 | $22 |
| Biotronik NRO, Inc. | 1 | $19 |
| Hydrofera LLC | 1 | $17 |
| AbbVie | 1 | $16 |
| Axogen | 1 | $16 |
| Convatec Inc. | 1 | $16 |
| Zimvie Inc. | 1 | $15 |
| Baxter Healthcare | 1 | $13 |
| Abbott | 1 | $12 |
| Reprise Biomedical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$35,081
- Low Profile Locking Plate, 4 Holes$4,513
- Low Profile Locking Plate, 5 Holes$4,513
- Low Profile Locking Plate, 6 Holes$4,513
- Low Profile Locking Plate, 3 Holes$4,306
- Low Profile Locking Plate, 7 Holes$4,281
- Iovera$800
- Zilretta$320
- Low Profile Locking Plate, 8 Holes$233
- Lapiplasty System$206
- VersaWrap$183
- HOFFMANN$171
- CITREFIX$171
- Qutenza$161
- DynaNail$154
- DynaNail Helix, Washer, 15 mm$147
- CellerateRx$116
- PuraPly$103
How this compares
$48,639 in reported general payments places this provider in the 95th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 26 | $480 |
| Gabapentin | 35 | $257 |
| Allopurinol | 12 | $163 |
| Meloxicam | 17 | $74 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Atlanta
- Mohammad SharifAtlanta$79K
- Margo JimenezAtlanta$19K
- Christopher BergenAtlanta$8K
- Guang YangAtlanta$8K
- Apeksha ReddyAtlanta$7K
- Brent Blanck-SingerAtlanta$6K
- Dane UlettAtlanta$5K
- Gisele YouthAtlanta$4K
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.